Eradication therapy for Helicobacter pylori.
Eradication therapy for Helicobacter pylori is recommended in a number of clinical conditions. In this article, we discuss the epidemiology and cellular mechanisms that result in antimicrobial resistance, the results of current eradication therapies, and new approaches to the management of Helicobacter pylori infection.
Vakil
Nimish
N
Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. nvakil@wisc.edu
Megraud
Francis
F
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D024881:Drug Resistance, Bacterial / Q000502:physiology; D004359:Drug Therapy, Combination; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000191:economics / Q000453:epidemiology; D016480:Helicobacter pylori / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D054328:Proton Pump Inhibitors; D055502:Secondary Prevention
D000900:Anti-Bacterial Agents; D054328:Proton Pump Inhibitors